Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KCNA5 | P22460 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13339074 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CYP2D6CYP2C19HSD17B10KCNA5 | |
| SCHEMBL4489962 | 0.82 | CYP2D6 (0.41) | ALDH1A1CYP2D6CYP2C19HSD17B10KCNA5 | |
| SCHEMBL301345 | 0.80 | ALDH1A1 (0.57) | ALDH1A1CYP2D6CYP2C19HSD17B10KCNA5 | |
| SCHEMBL6021075 | 0.80 | ALDH1A1 (0.57) | ALDH1A1CYP2D6CYP2C19HSD17B10KCNA5 | |
| SCHEMBL28600445 | 0.80 | CYP2D6 (0.42) | ALDH1A1CYP2D6CYP2C19HSD17B10KMT2A | |
| SCHEMBL17790421 | 0.79 | KMT2A (0.48) | ALDH1A1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL28658365 | 0.79 | HTT (0.40) | ALDH1A1CYP2D6CYP2C19HSD17B10MEN1 | |
| SCHEMBL8897023 | 0.78 | ALDH1A1 (0.39) | ALDH1A1CYP2D6CYP2C19HSD17B10KCNA5 | |
| SCHEMBL28354246 | 0.78 | CRHBP (0.43) | ALDH1A1CYP2D6CYP2C19HSD17B10KCNA5 | |
| SCHEMBL28024684 | 0.78 | CYP2D6 (0.46) | ALDH1A1CYP2D6CYP2C19HSD17B10KCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4508101-B1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4709518-A1 | PROCESS FOR THE PREPARATION OF POLYISOBUTENE FROM OLEFINS FROM ISOBUTANOL OBTAINED FROM MIXED GUERBET REACTION OF ETHANOL AND METHANOL | BASF SE (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4667447-A1 | PROCESS FOR THE PREPARATION OF POLYISOBUTENE FROM BIO-BASED OLEFINS FROM PRIMARY ALCOHOL | BASF SE (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-20250250382-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-08-07 | — | — | US | disclosed |
| US-20250250403-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-08-07 | — | — | US | disclosed |
| US-20250179224-A1 | MEDIUM MOLECULAR POLYISOBUTENE WITH A CERTAIN DISTRIBUTION OF DOUBLE BOND ISOMERS | BASF SE (DE) | 2025-06-05 | — | — | US | disclosed |
| US-20250145742-A1 | MEDIUM MOLECULAR POLYISOBUTENE WITH A HIGH CONTENT OF CERTAIN DOUBLE BOND ISOMERS | BASF SE (DE) | 2025-05-08 | — | — | US | disclosed |
| WO-2025082909-A1 | PROCESS FOR IMPROVING THE STABILITY OF POLYISOBUTENES | BASF SE (DE) | 2025-04-24 | — | — | WO | disclosed |
| EP-4508100-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-02-19 | — | — | EP | disclosed |
| EP-4508101-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-02-19 | — | — | EP | disclosed |
| US-8349977-B2 | Process for preparing high-reactivity isobutene homo- or copolymers | BASF SE (DE) | 2013-01-08 | — | — | US | disclosed |
| US-20120271058-A1 | STEREOSELECTIVE SYNTHESIS OF VITAMIN D ANALOGUES | SABROE THOMAS PETER (DK) | 2012-10-25 | — | — | US | disclosed |
| US-20120165473-A1 | PREPARATION OF DERIVATIVES OF ISOBUTENE COPOLYMERS | BASF SE (DE) | 2012-06-28 | — | — | US | disclosed |
| US-20120142868-A1 | PREPARATION OF ISOBUTENE HOMO- OR COPOLYMER DERIVATIVES | BASF SE (DE) | 2012-06-07 | — | — | US | disclosed |
| US-20110201772-A1 | PROCESS FOR PREPARING HIGH-REACTIVITY ISOBUTENE HOMO- OR COPOLYMERS | BASF SE (DE) | 2011-08-18 | — | — | US | disclosed |
| EP-1751170-A1 | CHIRAL PHOSPHORUS COMPOUNDS | UNIVERSITY COLLEGE DUBLIN (IE) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005118603-A1 | CHIRAL PHOSPHORUS COMPOUNDS | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-12-15 | — | — | WO | disclosed |
| US-5874436-A | EFFECTIVE IN INHIBITING THE ACTION OF A BACTERIAL HISTIDINE PROTEIN KINASE; USEFUL AGAINST ANTIBIOTIC RESISTANT ORGANISMS | DEMERS JAMES P (US) | 1999-02-23 | — | — | US | disclosed |
| WO-1997048676-A1 | TRIPHENYLALKYL ANTIMICROBIAL AGENTS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1997-12-24 | — | — | WO | disclosed |
| US-5643950-A | INHIBITORS OF A BACTERIAL HISTIDINE PROTEIN KINASE | ORTHO PHARMACEUTICAL CORPORATION (US) | 1997-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120271058-A1 | STEREOSELECTIVE SYNTHESIS OF VITAMIN D ANALOGUES | CYP24A1, CYP2R1, VDR | ALDH1A1 615/4885CYP2D6 202/4885CYP2C19 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.